CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 120 filers reported holding CUREVAC N V in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,855 | +2.4% | 18,866 | +56.2% | 0.00% | – |
| Q2 2023 | $125,863 | -76.7% | 12,079 | -69.6% | 0.00% | -100.0% |
| Q2 2022 | $540,000 | +1.5% | 39,700 | +46.5% | 0.00% | -50.0% |
| Q1 2022 | $532,000 | +53.8% | 27,094 | +168.4% | 0.00% | +100.0% |
| Q4 2021 | $346,000 | -89.8% | 10,094 | -83.8% | 0.00% | -92.3% |
| Q3 2021 | $3,404,000 | +25.9% | 62,323 | +69.4% | 0.01% | +30.0% |
| Q2 2021 | $2,704,000 | +1040.9% | 36,800 | +1315.4% | 0.01% | +900.0% |
| Q1 2021 | $237,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $107,600,000 | 32.65% |
| Affinity Asset Advisors, LLC | 50,000 | $1,716,000 | 0.62% |
| Renaissance Capital LLC | 21,659 | $743,000 | 0.19% |
| Eversept Partners, LP | 85,017 | $2,916,933 | 0.19% |
| TWINBEECH CAPITAL LP | 67,504 | $2,316,000 | 0.13% |
| Alpine Global Management, LLC | 23,033 | $790,000 | 0.12% |
| Paradigm Financial Advisors, LLC | 13,535 | $464,000 | 0.10% |
| Caption Management, LLC | 200,000 | $6,860,000 | 0.08% |
| Baillie Gifford | 3,923,340 | $134,610,000 | 0.07% |
| Donoghue Forlines LLC | 11,570 | $397,000 | 0.07% |